Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Origlieri C et al. – Study design, including the method and timing of scoring ocular symptoms, is an important factor affecting whether changes in ocular symptoms are detected in INS clinical trials. INS are thought to exert their influence on the eye through the naso–ocular reflex, and to date their impact on ocular symptoms appears to be a class effect.


Today in Allergy/Anaphylaxis...keeping you current

Oral Allergy Syndrome
Allergology International, 10/30/09

Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09

Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09

Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09

Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09

Today in Neurologic/Ophthalmic...keeping you current

Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
Therapeutic Advances in Neurological Disorders, 11/10/09

The management of allergic eye diseases in primary eye care
Contact Lens and Anterior Eye, 11/03/09

Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Archives of Neurology, 11/19/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address